Results 1 to 10 of about 9,717,883 (154)

Effects of Monacolin K in Nondiabetic Patients with NAFLD: A Pilot Study. [PDF]

open access: yesNutrients, 2023
Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver condition with significant risk of progression to steatohepatitis and cirrhosis. Therapeutic strategies in NAFLD include lifestyle changes mainly related to dietary interventions and use of drugs or nutritional components that could improve plasma lipid profiles and insulin sensitivity
Da Porto A   +10 more
europepmc   +7 more sources

Glutamic acid promotes monacolin K production and monacolin K biosynthetic gene cluster expression in Monascus. [PDF]

open access: yesAMB Express, 2017
This study investigated the effects of glutamic acid on production of monacolin K and expression of the monacolin K biosynthetic gene cluster. When Monascus M1 was grown in glutamic medium instead of in the original medium, monacolin K production increased from 48.4 to 215.4 mg l-1, monacolin K production increased by 3.5 times.
Zhang C   +6 more
europepmc   +6 more sources

Improvement of Monacolin K and Pigment Production in Monascus by 5-Azacytidine. [PDF]

open access: yesJ Fungi (Basel)
Monascus species are known to produce various secondary metabolites with polyketide structures, including Monacolins, pigments, and citrinin. This study investigates the effects of 5-azacytidine on Monascus M1 and RP2. The dry weight, red, yellow, and orange pigment values, and Monacolin K yield of both Monascus strains were measured, and their hyphae ...
Zhang C   +10 more
europepmc   +5 more sources

Red yeast rice with monacolin K for the improvement of hyperlipidemia: A narrative review. [PDF]

open access: yesWorld J Clin Cases
Low-density lipoprotein cholesterol (LDL-C) is the most causal risk factor for atherosclerotic cardiovascular disease (ASCVD). Red yeast rice (RYR) is a nutraceutical widely used as a lipid-lowering dietary supplement. The main cholesterol-lower agents in RYR are monacolins, particularly monacolin K, a weak reversible inhibitor of 3-hydroxy-3-methyl ...
English K.
europepmc   +3 more sources

Metabolomics Analysis of the Effect of Glutamic Acid on Monacolin K Synthesis in Monascus purpureus. [PDF]

open access: yesFront Microbiol, 2020
Monacolin K is a secondary metabolite produced by Monascus with beneficial effects on health, including the ability to lower cholesterol. We previously showed that the yield of monacolin K was significantly improved when glutamic acid was added to the fermentation broth of Monascus purpureus M1. In this study, we analyzed M. purpureus in media with and
Zhang C   +7 more
europepmc   +5 more sources

NaCl Inhibits Citrinin and Stimulates Monascus Pigments and Monacolin K Production. [PDF]

open access: yesToxins (Basel), 2019
Applications of beneficial secondary metabolites produced by Monascus purpureus (M. purpureus) could be greatly limited for citrinin, a kidney toxin. The link of NaCl with cell growth and secondary metabolites in M. purpureus was analyzed with supplementations of different concentrations of NaCl in medium.
Zhen Z   +6 more
europepmc   +5 more sources

Approaches to Authenticating Products Containing Red Yeast Rice Extract (Monacolin K). [PDF]

open access: yesMolecules
Red yeast rice (RYR) food supplements are widely used for cholesterol management owing to their content of monacolin K (MK), which, in its lactone form, is chemically identical to the prescription statin lovastatin. Despite their popularity, RYR products raise significant quality and safety concerns related to pronounced variability in MK content ...
Ivanova S   +4 more
europepmc   +3 more sources

The Role of Enoyl Reductase in the Monacolin K Biosynthesis Pathway in <i>Monascus</i> spp. [PDF]

open access: yesJ Fungi (Basel)
Monacolin K (MK), a secondary metabolite produced by Monascus spp. with the ability to inhibit cholesterol production, is structurally identical to lovastatin produced by Aspergillus terreus. In the lovastatin biosynthetic pathway, the polyketide synthase (PKS) encoded by lovB must work together with the enoyl reductase encoded by lovC to ensure ...
Yao T, Wang X, Chen F.
europepmc   +4 more sources

Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome. [PDF]

open access: yesBiomed Pharmacother, 2018
Metabolic syndrome (MetS) is a world-wide epidemic disease with an increased risk of morbidity and mortality. Treatment strategies of MetS include pharmacologic and non-pharmacologic interventions and in this respect a relevant role has been shown for nutraceutical compounds (NCs). The aim of this study was to investigate the efficacy and safety of NCs
Mazza A   +8 more
europepmc   +4 more sources

A Monascus pilosus MS-1 strain with high-yield monacolin K but no citrinin. [PDF]

open access: yesFood Sci Biotechnol, 2016
Monacolin K (MK) produced by Monascus spp. is mostly used to regulate cholesterol level, while it can be contaminated by citrinin, a mycotoxin yielded by some Monascus strains. To develop production of citrinin-free MK, an M. sp. MS-1 strain, identified as M.
Feng Y, Chen W, Chen F.
europepmc   +4 more sources

Home - About - Disclaimer - Privacy